ASPIRIN
Clinical trials for ASPIRIN explained in plain language.
Never miss a new study
Get alerted when new ASPIRIN trials appear
Sign up with your email to follow new studies for ASPIRIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as using two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 partici…
Matched conditions: ASPIRIN
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Aspirin shield: could a simple pill protect moms and babies from deadly pregnancy risks?
Prevention Recruiting nowThis study tests whether taking 150 mg of aspirin daily, starting before the 20th week of pregnancy, can prevent serious complications like preeclampsia, poor fetal growth, placental abruption, preterm birth, and death in pregnant women with chronic high blood pressure. About 500…
Matched conditions: ASPIRIN
Phase: PHASE3 • Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Prevention
Last updated May 15, 2026 11:57 UTC
-
Can a simple aspirin switch save lives? new study tests best dose for diabetics
Knowledge-focused Recruiting nowThis study looks at how well different forms and doses of daily aspirin work in people with type 2 diabetes to prevent blood clots. About 30 participants will first take a standard coated aspirin for a week. Those whose blood does not respond well will then try three other aspiri…
Matched conditions: ASPIRIN
Phase: PHASE1 • Sponsor: Montreal Heart Institute • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC